Ken Shimada

2.0k total citations
104 papers, 1.3k citations indexed

About

Ken Shimada is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ken Shimada has authored 104 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Ken Shimada's work include Colorectal Cancer Treatments and Studies (42 papers), Gastric Cancer Management and Outcomes (34 papers) and Cancer Treatment and Pharmacology (27 papers). Ken Shimada is often cited by papers focused on Colorectal Cancer Treatments and Studies (42 papers), Gastric Cancer Management and Outcomes (34 papers) and Cancer Treatment and Pharmacology (27 papers). Ken Shimada collaborates with scholars based in Japan, United States and China. Ken Shimada's co-authors include Jaffer A. Ajani, Katsuhiro Uzawa, Hideki Tanzawa, Yasutsuna Sasaki, Atsushi Kasamatsu, Masashi Shiiba, Yu Sunakawa, Masato Nakamura, Yasuhide Yamada and Satoshi Morita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ken Shimada

97 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Shimada Japan	22	694	437	312	260	147	104	1.3k
Kazuhiko Yoshimatsu Japan	17	554 0.8×	298 0.7×	394 1.3×	218 0.8×	144 1.0×	184	1.2k
Angelica Petrillo Italy	19	551 0.8×	350 0.8×	237 0.8×	233 0.9×	165 1.1×	68	1.1k
Prachi Patil India	17	687 1.0×	372 0.9×	565 1.8×	322 1.2×	157 1.1×	85	1.3k
Keigo Ashida Japan	21	629 0.9×	309 0.7×	400 1.3×	192 0.7×	154 1.0×	63	1.2k
Daniel Motola‐Kuba Mexico	17	481 0.7×	319 0.7×	230 0.7×	218 0.8×	257 1.7×	49	1.3k
Kenji Katsumata Japan	18	828 1.2×	491 1.1×	618 2.0×	196 0.8×	145 1.0×	174	1.4k
Luigi Rossi Italy	20	342 0.5×	332 0.8×	317 1.0×	400 1.5×	219 1.5×	58	1.5k
Uğur Çoşkun Türkiye	26	862 1.2×	557 1.3×	338 1.1×	535 2.1×	281 1.9×	174	2.3k
George I. Salti United States	21	690 1.0×	486 1.1×	624 2.0×	337 1.3×	81 0.6×	76	1.8k
Mitsukuni Suenaga Japan	21	1.1k 1.6×	533 1.2×	240 0.8×	271 1.0×	332 2.3×	149	1.5k

Countries citing papers authored by Ken Shimada

Since Specialization

Citations

This map shows the geographic impact of Ken Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Shimada more than expected).

Fields of papers citing papers by Ken Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Shimada. The network helps show where Ken Shimada may publish in the future.

Co-authorship network of co-authors of Ken Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Shimada. A scholar is included among the top collaborators of Ken Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Shimada. Ken Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagata, Takuya, Ayako Watanabe, Kenji Momo, et al.. (2023). Dexamethasone to prednisolone rotation relieved hiccups in colorectal cancer patient continuing teleworking during anticancer therapy. SHILAP Revista de lepidopterología. 11(6). e7367–e7367. 2 indexed citations

Watanabe, Ayako, et al.. (2023). Transient EDTA‐dependent pseudothrombocytopenia and ulcerative colitis recurrence during chemotherapy: A case of misleading platelet count results attributable to a laboratory artifact. SHILAP Revista de lepidopterología. 11(11). e8153–e8153. 1 indexed citations

Shimada, Ken, Akihito Tsuji, Ho Min Kim, et al.. (2022). Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen. Anticancer Research. 42(5). 2675–2681. 2 indexed citations

Momo, Kenji, et al.. (2020). Severe Drowsiness with Fever Induced by Transdermal Fentanyl Administration. Journal of Palliative Medicine. 23(8). 1006–1008. 1 indexed citations

Yamada, Yasuhide, Wasaburo Koizumi, Kazuhiro Nishikawa, et al.. (2019). Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer. Cancer Science. 110(9). 2875–2883. 12 indexed citations

Sunakawa, Yu, Kaoru Mogushi, Heinz‐Josef Lenz, et al.. (2018). Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer. Molecular Cancer Therapeutics. 17(12). 2788–2795. 3 indexed citations

Shimada, Ken, et al.. (2018). A case of neuroleptic malignant syndrome following surgery for maxillofacial fractures. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 30(5). 413–417.

Baba, Hideo, Yasuhide Yamada, Daisuke Takahari, et al.. (2017). S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT study. ESMO Open. 2(1). e000135–e000135. 15 indexed citations

Sunakawa, Yu, Wataru Ichikawa, Akihito Tsuji, et al.. (2016). Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials. Clinical Colorectal Cancer. 16(3). e171–e180. 37 indexed citations

10.

Shimada, Ken, et al.. (2016). [A Case of HER2-Positive Esophagogastric Junction Cancer with Perforation Curatively Resected after Neoadjuvant Chemotherapy plus Trastuzumab].. PubMed. 43(6). 761–4. 1 indexed citations

11.

Saeki, Toshiaki, Kazuhiro Araki, Ken Shimada, et al.. (2016). Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. International Cancer Conference Journal. 5(4). 178–182.

12.

Watanabe, Naoki, et al.. (2015). Retrospective analysis of cardiac tolerability of concurrent administration of trastuzumab and anthracycline-based regimen for breast cancer, to address one-year-term issues in LVEF. Breast Disease. 35(4). 253–261. 1 indexed citations

13.

Nakayama, Norisuke, Atsushi Satō, Soichi Tanaka, et al.. (2015). A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study. Investigational New Drugs. 33(4). 954–962. 2 indexed citations

14.

Shimada, Ken & Jun Morita. (2013). Bioequivalence in Safety and Pharmacokinetics of Fentanyl Tape for 3 Days after a Single Application in Japanese Healthy Male Subjects Co-Administrated Naltrexone Hydrochloride. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 44(4). 307–312.

15.

Tsuji, Akihito, Masato Nakamura, Yu Sunakawa, et al.. (2013). A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05). Annals of Oncology. 24. iv94–iv94. 4 indexed citations

16.

Ogawara, Katsunori, Ken Shimada, Takashi Ishigami, et al.. (2012). A case of basaloid squamous cell carcinoma of the lower gingiva. Japanese Journal of Oral & Maxillofacial Surgery. 58(9). 536–540. 1 indexed citations

17.

Yoshikawa, Takaki, Akira Tsuburaya, Ken Shimada, et al.. (2009). A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer. 12(4). 212–218. 4 indexed citations

18.

Shimada, Ken, et al.. (1998). A Case of Choriocarcinoma of the Duodenum.. The Japanese Journal of Gastroenterological Surgery. 31(5). 1102–1106.

19.

Uchida, Eiji, Naoki Uchida, Takayoshi Oguma, et al.. (1997). Evaluation of Pharmacokinetic-pharmacodynamic Relationship of Nitrazepam Using Computerized Eye Movement Analysis and Visual Analogue Scales in Healthy Japanese Volunteers.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 28(3). 703–713. 2 indexed citations

20.

Uchida, Eiji, Takayoshi Oguma, Naoki Uchida, et al.. (1995). Contribution of Non-renal Clearance to the Elimination of Vancomycin during Repeated Intravenous Administration in Elderly Patients.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 26(3). 743–751. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact